IN2014MN01805A - - Google Patents

Download PDF

Info

Publication number
IN2014MN01805A
IN2014MN01805A IN1805MUN2014A IN2014MN01805A IN 2014MN01805 A IN2014MN01805 A IN 2014MN01805A IN 1805MUN2014 A IN1805MUN2014 A IN 1805MUN2014A IN 2014MN01805 A IN2014MN01805 A IN 2014MN01805A
Authority
IN
India
Prior art keywords
bioadhesive
disclosed
matrix
bioactive agent
formulation
Prior art date
Application number
Other languages
English (en)
Inventor
Meital Zilberman
PELEG Adaya SHEFY
Binyamin Cohen
Maytal Foox
Original Assignee
Technology Innovation Momentum Fund Israel Ltd Partnership
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technology Innovation Momentum Fund Israel Ltd Partnership filed Critical Technology Innovation Momentum Fund Israel Ltd Partnership
Publication of IN2014MN01805A publication Critical patent/IN2014MN01805A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/104—Gelatin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/04—Alginic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Dermatology (AREA)
IN1805MUN2014 2012-02-16 2013-02-14 IN2014MN01805A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261599486P 2012-02-16 2012-02-16
PCT/IL2013/050139 WO2013121429A1 (en) 2012-02-16 2013-02-14 Formulations and kits for forming bioadhesive matrices

Publications (1)

Publication Number Publication Date
IN2014MN01805A true IN2014MN01805A (zh) 2015-07-03

Family

ID=48983623

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1805MUN2014 IN2014MN01805A (zh) 2012-02-16 2013-02-14

Country Status (7)

Country Link
US (3) US9877926B2 (zh)
EP (1) EP2814511B1 (zh)
CN (2) CN107617123A (zh)
CA (1) CA2864075A1 (zh)
HK (1) HK1245682A1 (zh)
IN (1) IN2014MN01805A (zh)
WO (1) WO2013121429A1 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013121429A1 (en) 2012-02-16 2013-08-22 Ramot At Tel-Aviv University Ltd. Formulations and kits for forming bioadhesive matrices
EP2974752A4 (en) * 2013-03-13 2016-10-19 Nat Inst For Materials Science ADHESIVE BONE FILLER AND ADHESIVE BONE FILLER KIT
BR112018007892A2 (pt) * 2015-10-28 2018-10-30 Tech Innovation Momentum Fund Israel Limited Partnership selante bioadesivo compósito
CN106975097A (zh) * 2017-03-02 2017-07-25 四川大学 一种生物医用黏合水凝胶及其制备方法
WO2018197946A1 (en) * 2017-04-26 2018-11-01 Meital Zilberman Hydrogel compositions including fibers and methods of use thereof
TW201932124A (zh) * 2018-01-18 2019-08-16 近鎰生技股份有限公司 止血材料、其製備方法及包含其的藥物組合物
IL257357A (en) * 2018-02-05 2018-03-29 Univ Ramot Injectable scaffolds and their uses
CN108478849B (zh) * 2018-02-07 2021-04-16 广州迈普再生医学科技股份有限公司 一种可吸收可黏附止血海绵及其制备方法
CN108785732B (zh) * 2018-06-21 2021-04-09 广州迈普再生医学科技股份有限公司 止血封堵材料及其制备方法和止血封堵制品
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices
CN110917389B (zh) * 2018-09-20 2022-03-22 广州迈普再生医学科技股份有限公司 一种组织封闭组合物、组织封堵胶及其制备方法
CN111744053A (zh) * 2020-05-19 2020-10-09 湖北大学 双网络外科胶黏剂及其制备方法
US11643574B2 (en) 2021-05-28 2023-05-09 Cohesys Inc. Adhesive devices and uses thereof
CN115814148B (zh) * 2022-12-26 2024-07-16 四川大学华西医院 一种快速自凝胶化止血粉及其制备方法和用途

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082147A (en) 1988-02-29 1992-01-21 Richard Jacobs Composition dispensing system
US4979942A (en) 1989-10-16 1990-12-25 Johnson & Johnson Medical, Inc. Two component syringe delivery system
US5284659A (en) 1990-03-30 1994-02-08 Cherukuri Subraman R Encapsulated flavor with bioadhesive character in pressed mints and confections
US5827247A (en) * 1991-08-20 1998-10-27 Bioderm External incontinence device and vapor-absorptive adhesive compositions
DE69510190T2 (de) 1994-03-30 2000-01-27 Gs Dev Ab Verwendung von fettsäureester als bioklebstoffe
KR20010013105A (ko) * 1997-05-28 2001-02-26 시미즈, 야스히꼬 콜라겐 겔
US20020022588A1 (en) * 1998-06-23 2002-02-21 James Wilkie Methods and compositions for sealing tissue leaks
US20030083286A1 (en) 2001-08-22 2003-05-01 Ching-Leou Teng Bioadhesive compositions and methods for enhanced intestinal drug absorption
US6732887B2 (en) 2002-03-26 2004-05-11 Ultradent Products, Inc. Two-part composition syringe delivery system
US20040156794A1 (en) 2003-02-11 2004-08-12 Barkalow David G. Bioerodible and bioadhesive confectionery products and methods of making same
US7530808B2 (en) 2004-03-10 2009-05-12 Cao Group, Inc Binary dental bleaching using switch-closable double barrel syringe
US20060013873A1 (en) 2004-07-16 2006-01-19 Chih-Chiang Yang Bioadhesive dosage form of steroids
UA88321C2 (ru) * 2004-09-30 2009-10-12 Ковалон Текнолоджиз Инк. Неадгезивные эластичные желатиновые матрицы
US8303972B2 (en) * 2005-04-19 2012-11-06 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US7635343B2 (en) 2005-04-21 2009-12-22 Arteriocyte Medical Systems, Inc. Fluid dispenser
EP1989004B1 (en) 2006-03-01 2019-04-03 Sulzer Mixpac AG Two-part double syringe
US20070289996A1 (en) 2006-06-19 2007-12-20 Todd Alan Wheatcraft Polyurethane and epoxy adhesive applicator systems
US7699803B2 (en) 2007-01-03 2010-04-20 Medtronic Vascular, Inc. Devices and methods for injection of multiple-component therapies
EP2200674A2 (en) 2007-09-10 2010-06-30 Boston Scientific Scimed, Inc. Medical devices with triggerable bioadhesive material
US20090099149A1 (en) 2007-10-11 2009-04-16 Wyeth Bioadhesive film
CN104888263B (zh) * 2008-01-14 2018-11-30 北京环球利康科技有限公司 生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料
CN102124058B (zh) * 2008-06-18 2014-05-28 生命连结有限公司 改进的交联组合物
DK2373321T3 (en) 2008-12-05 2016-06-13 Biomed Device S R L Biovedhæftende platelet lysate and compositions thereof for the treatment of mucostitis
US8314211B2 (en) 2009-04-07 2012-11-20 George Falus Tissue sealant for use in non compressible hemorrhage
CN101716366A (zh) * 2009-12-17 2010-06-02 天津大学 醛改性海藻酸钠和胺改性明胶的生物胶型止血剂
US8434643B2 (en) 2010-04-13 2013-05-07 Ryan Harris Dual chamber dispenser
WO2013121429A1 (en) 2012-02-16 2013-08-22 Ramot At Tel-Aviv University Ltd. Formulations and kits for forming bioadhesive matrices

Also Published As

Publication number Publication date
US20150038424A1 (en) 2015-02-05
CN104220096A (zh) 2014-12-17
US10265274B2 (en) 2019-04-23
CN104220096B (zh) 2017-10-20
CN107617123A (zh) 2018-01-23
WO2013121429A1 (en) 2013-08-22
US9877926B2 (en) 2018-01-30
HK1245682A1 (zh) 2018-08-31
EP2814511A4 (en) 2015-10-07
CA2864075A1 (en) 2013-08-22
EP2814511A1 (en) 2014-12-24
US20190262276A1 (en) 2019-08-29
EP2814511B1 (en) 2021-10-20
US20180133164A1 (en) 2018-05-17

Similar Documents

Publication Publication Date Title
IN2014MN01805A (zh)
CY1119616T1 (el) Συζευγματα ανθρωπινου αντισωματος-φαρμακου κατα του ιστικου παραγοντα
MX2019011215A (es) Ácidos nucleicos que codifican proteínas asociadas a crispr y usos de los mismos.
MX2015012433A (es) Matriz de microestructura para suministro de agentes activos.
WO2012018446A3 (en) Anchor delivery system
ZA201400616B (en) Methods and devices for drug delivery to ocular tissue using microneedle
MX2014016107A (es) Derivados de tienopiridona utiles como activadores de ampk.
ZA201109396B (en) Implantable drug delivery devices and methods of making the same
EP2811939A4 (en) METHOD AND USES OF BIOLOGICAL TISSUE FOR DIFFERENT STENTS AND OTHER MEDICAL APPLICATIONS
PH12015502854A1 (en) Methods, systems, and compositions for promoting bone growth
MX2011013150A (es) Composicion farmaceutica para uso en oftalmologia medica y veterinaria.
PL3064579T3 (pl) Kompozycje farmaceutyczne i zastosowania medyczne uzyskanych metodami inżynierii ludzkich arginaz
WO2011049958A3 (en) Modulation of gel temperature of poloxamer-containing formulations
WO2012100206A3 (en) Mri markers, delivery and extraction systems, and methods of manufacture and use thereof
WO2013028942A8 (en) Targeting microbubbles
HUS2400027I1 (hu) Rekombináns humán G-CSF dimer és alkalmazása, neurológiai betegségek kezelésében
MY173215A (en) Acetylcysteine compositions and methods of use thereof
MX2013014461A (es) Formulaciones de liberacion sostenida para el suministro de proteinas al ojo y metodos para prepararlas.
MX366230B (es) Composiciones multipolimericas para liberación transdermica de farmaco.
EP2488210A4 (en) METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION USING IN VITO OR IN VITRO-ADMINISTERED OLIGONUCLEOTIDE MEDICAMENTS
PH12015502556A1 (en) Modified release formulation
WO2012142328A3 (en) Polymer microsphere compositions for localized delivery of therapeutic agents
ATE512192T1 (de) Verwendung von kupplungsmitteln zur verbesserung der grenzfläche in resorbierbaren polymerverbunden
NZ630058A (en) Viscous haemostatic compostions and method of treatment
WO2011058245A8 (fr) Nouveaux derives de mannopyranoside ayant une activite anticancereuse